Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

CCA Industries, Inc. Reports Results of Operations for the Quarter ended February 29, 2024, and New Distribution

Published 2024-04-10, 04:46 p/m

FORT WASHINGTON, Pa., April 10, 2024 /PRNewswire/ --  CCA Industries, Inc. (OTC: CAWW), announced today its results for the three months ended February 29, 2024.   The results can be found in the chart below.

The net loss was $245,410 for the three months ended February 29, 2024, compared to a loss of $282,788 for the three months ended February 28, 2023. As shown in the chart below, EBITDA for the first quarter of fiscal 2024 was a loss of $288,499.   As a note, the brand Bikini Zone accounted for 25% of Q1 2023 sales and those sales are not included in Q1 2024 as the brand was sold in September 2023.   Christopher Dominello, Chief Executive Officer, commented, "We anticipated the loss for the first quarter of fiscal 2024 as we continued our turnaround efforts and 'set the table' for our latest news.   We are pleased to announce that our brand, Neutein, will be in 3,420 CVS stores across the country beginning May 2024.   We will begin an exciting marketing campaign for the brand featuring the NFL Hall of Fame football player Mike Singletary and other celebrities. We have also had interest from other retailers who want to consider carrying the brand.   As we mentioned in previous press releases, this is the start of the Company's turnaround."  

Further information, including the Unaudited Financial Statement for the first quarter ended February 29, 2024, the Audited Financial Statements for the year ended November 30, 2023, and the Quarterly Disclosure Statement filed with the OTC, may be found on the Company's investor web site:   www.ccainvestor.com    

CCA Industries, Inc. manufactures and markets health and beauty aids, each under its individual brand name. The products include, principally, "Plus White" toothpaste and teeth whiteners, "Nutra Nail" nail care treatments, "Porcelana" skin care products, "Scar Zone" scar treatment products, "Sudden Change" anti-aging skin care products, brands, "Hair Off" depilatory products, "Lobe Miracle" earlobe protection products and "Neutein" brain health supplements.  

Statements contained in the news release that are not historical facts are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks and uncertainties, which would cause actual results to differ materially, from estimated results. No assurance can be given that the results in any forward-looking statement will be achieved, and actual results could be affected by one or more factors, which could cause them to differ materially. For these statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act.

 

CCA INDUSTRIES, INC.

Financial Results (Unaudited)



Three Months Ended


February 29, 2024


February 28, 2023

Revenues

$                 2,134,581


$                                 2,467,726





Net Income

$                   (245,410)


$                                   (282,788)





Earnings Per Share:




Basic

$                         (0.03)


$                         (0.04)

Diluted

$                         (0.03)


$                         (0.04)





Weighted Average Common Shares Outstanding:




Basic

7,561,684


7,561,684

Diluted

7,561,684


7,561,684





EBITDA

$                  (288,499)


$                  (298,497)





Earnings before interest, taxes, depreciation and amortization







Reconciliation of Net Income to EBITDA:







Net Income

$                  (245,410)


$                  (282,788)

Provision for income taxes

(73,520)


(65,962)

Interest expense

28,951


48,954

Depreciation and Amortization

1,480


1,299

EBITDA

$                  (288,499)


$                  (298,497)





 

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.